Skip to main content
All lobbying filings

W STRATEGIES, LLC

Lobbying for GILEAD SCIENCES, INC. · American biotechnology company that researches, develops and commercializes drugs.

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $60,000.00 income · posted Jul 21, 2025

Official filing document

 Bills named in this filing 3
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic can…
  • HR 5376
    Impacts and Outcomes for Health Career Training Act
  • HR 1
    An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
 Lobbying activity 2
Medicare/Medicaid

H.R.1492 - EPIC Act. Implementation H.R.5376 - Inflation Reduction Act of 2022. H.R.1 - One Big Beautiful Bill Act.

Health Issues

Education about access to HIV medicines Education about the 340(b) program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem